Aerosol treatment with MNEI suppresses bacterial proliferation in a model of chronicPseudomonas aeruginosa lung infection

This publication has 36 references indexed in Scilit:

• Endotoxin Activity and Inflammatory Markers in the Airways of Young Patients with Cystic Fibrosis
  American Journal of Respiratory and Critical Care Medicine, 2002
• Lung Inflammation Early in Cystic Fibrosis
  American Journal of Respiratory and Critical Care Medicine, 2002
• Aerosolized Prolastin Suppresses Bacterial Proliferation in a Model of ChronicPseudomonas aeruginosa Lung Infection
  American Journal of Respiratory and Critical Care Medicine, 1999
• Proteinase 3, a Potent Secretagogue in Airways, Is Present in Cystic Fibrosis Sputum
  American Journal of Respiratory Cell and Molecular Biology, 1999
• Recombinant Human Monocyte/Neutrophil Elastase Inhibitor Protects Rat Lungs against Injury from Cystic Fibrosis Airway Secretions
  American Journal of Respiratory Cell and Molecular Biology, 1999
• Inflammatory cytokines in cystic fibrosis lungs.
  American Journal of Respiratory and Critical Care Medicine, 1995
• Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation.
  American Journal of Respiratory and Critical Care Medicine, 1994
• Protease-antiprotease imbalance in the lungs of children with cystic fibrosis.
  American Journal of Respiratory and Critical Care Medicine, 1994
• Release of Interleukin-8, Interleukin-6, and Colony-stimulating Factors by Upper Airway Epithelial Cells: Implications for Cystic Fibrosis
  American Journal of Respiratory Cell and Molecular Biology, 1993
• Studies on the Ability of Alginate to Act as a Protective Immunogen Against Infection with Pseudomonas aeruginosa in Animals
  The Journal of Infectious Diseases, 1985